Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sapiens International Earnings Release 2016

Nov 7, 2016

7031_rns_2016-11-07_4fa37ecc-1f2e-47d3-9707-8cc154a6ae23.pdf

Earnings Release

Open in viewer

Opens in your device viewer

Sapiens Reports Q3 2016 Financial Results

Double-Digit Growth Across All Geographies

Holon, Israel, November 7, 2016Sapiens International Corporation, (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, with a growing presence in the financial services sector, and a member of the Formula Group (NASDAQ: FORTY and TASE: FORT), today announced its financial results for the third quarter ended September 30, 2016.

Third Quarter Highlights:

  • GAAP Revenue of \$56.5 million, up 20.1% compared to \$47.0 million in the third quarter of 2015.
  • Non-GAAP revenue of \$56.5 million, up 22.4% compared to \$46.1 million in the third quarter of 2015.
  • GAAP Operating profit increased by 15.1% and totaled \$6.6 million (11.7% operating margin), compared to \$5.7 million (12.2% operating margin) in the third quarter of 2015.
  • Non-GAAP operating profit totaled \$7.3 million (13.0% operating margin), compared to \$7.0 million (15.1% operating margin) in the third quarter of 2015.
  • GAAP Net income attributable to Sapiens' shareholders totaled \$5.3 million or \$0.11 per diluted share, an increase of 13.1% compared to \$4.7 million or \$0.09 per diluted share in the third quarter last year.
  • Non-GAAP net income attributable to Sapiens' shareholders totaled \$6.0 million or \$0.12 per diluted share, an increase of 3.2% compared to \$5.8 million or \$0.12 per diluted share in the third quarter last year.
  • Cash, cash equivalents and securities investments as of September 30, 2016 were \$96.7 million and the company has no debt.

"We saw strong double-digit growth and improved performance across all of our offerings and across all of our territories, driven by strong demand from existing customers and from ramping sales from new customers. As in recent quarters, the demand for our products and services remained strong,"

said Roni Al-Dor, President and CEO of Sapiens. "I remain very encouraged by our geographic expansion, our organic growth with both new and existing customers and the potential for ongoing M&A opportunities to enhance our growth and profitability."

Mr. Al-Dor continued. "On the deal front, we had a very busy third quarter. We expanded our strategic relationship with the Medical Protection Society (MPS) with a new multi-million dollar agreement to lead the complex implementation of the MPS' membership system. In addition, Menora Mivtachim Insurance in Israel selected Sapiens IDIT suite in a new agreement valued at over \$10 million. In another multi-million Euro agreement, LB Group selected the Sapiens IDIT P&C suite as its new policy administration solution, and last Generali Nederland, one of the largest European insurance providers, selected the Sapiens solution to manage its life portfolios."

"In addition to our various customer wins and engagements, during the third quarter we announced the upcoming launch of several new products and capabilities. By the first quarter of 2017, Sapiens ALIS policy administration solution will be expanded to include support for Group Life, and will support the whole range of hybrid group, worksite and individual life solutions on a single platform. Also, Sapiens launched a consumer and agent PORTAL for Life and P&C insurers. The Sapiens PORTAL along with Sapiens INTELLIGENCE will enable our customers to provide both consumers and agents a complete digital experience."

Mr. Al-Dor concluded: "Our business plan remains intact and attainable. We maintain our guidance for 2016 full year revenues of \$211 to \$215 million, or annual growth of 18%-20%, and we continue to expect full-year 2016 non-GAAP operating margins in the range of 13.5% - 14.0%, reflecting previously announced increased short-term investments in delivery, R&D, sales and marketing."

Quarterly Results Conference Call

Management will host a conference call and webcast on November 7 at 9:30 a.m. Eastern Time (4:30 p.m. in Israel) to review and discuss Sapiens' results.

Please call the following numbers (at least 10 minutes before the scheduled time) to participate: North America (toll-free): + 1-888-281-1167; International: +972-3-918-0685; UK: 0-800-917-9141 The live webcast of the call can be viewed on Sapiens' website at:

http://www.sapiens.com/investors/presentations-and-webcast/

If you are unable to join live, a replay of the call will be accessible until November 21, 2016, as follows: North America: 1-888-269-0005; International: +972-3-925-5929

A recorded version of the webcast will also be available via the Sapiens website, for three months at the same location.

Non-GAAP Financial Measures

This press release contains the following non-GAAP financial measures: Non-GAAP revenue, Non-GAAP gross profit, Non-GAAP operating income, Non-GAAP net income attributed to Sapiens shareholders, Non-GAAP basic and diluted earnings per share.

Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens' financial condition and results of operations. The Company's management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company's board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing the Company's financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

Management of the Company does not consider these non-GAAP measures in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures. In order to compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company's business.

In addition, the Company adjusted revenues and expenses, recorded under US GAAP, of preacquisition date in respect of acquired business from its ultimate parent company. As this transaction is between companies under common control, under US GAAP, it was accounted for under the

pooling of interest method. For non-GAAP measurement purposes, the Company excludes the preacquisition date revenues and expenses.

Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.

The Company defines Adjusted EBITDA as net Profit, adjusted for stock-based compensation expense, depreciation and amortization, capitalized internal-use software development costs, amortization of internal-use software development costs interest expense, compensation expenses related to acquisition, pre-acquisition revenues and expenses accounted under pooling of interest method, provision for income taxes and other income (expenses). These amounts are often excluded by other companies to help investors understand the operational performance of their business. The Company uses Adjusted EBITDA as a measurement of its operating performance because it assists in comparing the operating performance on a consistent basis by removing the impact of certain noncash and non-operating items. Adjusted EBITDA reflect an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures provide a more complete understanding of factors and trends affecting its business.

About Sapiens

Sapiens International Corporation (NASDAQ and TASE: SPNS) is a leading global provider of software solutions for the insurance industry, with an emerging focus on the broader financial services sector. We offer core, end-to-end solutions to the global general insurance, property and casualty, life, pension and annuities, and retirement markets, as well as business decision management software. We have a track record of over 30 years in delivering superior software solutions to more than 200 financial services organizations. The Sapiens team of approximately 1,900 professionals operates through our fully-owned subsidiaries in North America, the United Kingdom, EMEA and Asia Pacific. For more information: www.sapiens.com.

Forward Looking Statement

Some of the statements in this press release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities and Exchange Act of 1934 and the United States Private Securities Litigation Reform Act of 1995. Words such as "will," "expects," "believes" and similar expressions are used to identify these forward-looking statements (although not all forward-looking statements include such words). These forward-looking statements,

which may include, without limitation, projections regarding our future performance and financial condition, are made on the basis of management's current views and assumptions with respect to future events. Any forward-looking statement is not a guarantee of future performance and actual results could differ materially from those contained in the forward-looking statement.

These statements speak only as of the date they were made, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. We operate in a changing environment. New risks emerge from time to time and it is not possible for us to predict all risks that may affect us. For more information regarding these risks and uncertainties, as well as certain additional risks that we face, please refer to the Risk Factors detailed in Item 3 of Part III of our Annual Report on Form 20-F for the year ended December 31, 2015, and subsequent reports and registration statements filed from time to time with the Securities and Exchange Commission.

Investors and Media Contact:

Yaffa Cohen-Ifrah Chief Marketing Officer and Head of Corporate Communications Sapiens International US Mobile: +1 201-250-9414 Mobile: +972 54-9099039 Email: [email protected]

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

U.S. dollars in thousands (except per share amounts)

Three months ended
September 30,
Nine months ended
September 30,
2016
2015*
2016 2015*
(unaudited) (unaudited) (unaudited) (unaudited)
Revenue 56,480 47,035 159,077 136,962
Cost of revenue 34,366 27,944 95,754 82,559
Gross profit 22,114 19,091 63,323 54,403
Operating Expenses:
Research and development, net 4,147 2,482 11,401 7,488
Selling, marketing, general and administrative 11,376 10,883 32,673 29,361
Total operating expenses 15,523 13,365 44,074 36,849
Operating income 6,591 5,726 19,249 17,554
Financial expense (income), net (225) (105) (631) 239
Taxes and other expenses, net 1,463 1,127 4,389 3,021
Net income 5,353 4,704 15,491 14,294
Attributable to non-controlling interest 48 15 (34) 150
Net income attributable to Sapiens' shareholders 5,305 4,689 15,525 14,144
Basic earnings per share** 0.11 0.10 0.32 0.30
Diluted earnings per share** 0.11 0.09 0.32 0.29
Weighted average number of shares outstanding used to
compute basic earnings per share (in thousands)
49,002 48,128 48,922 47,869
Weighted average number of shares outstanding used to
compute diluted earnings per share (in thousands)
49,849 49,484 49,722 49,254

* Including consolidation of Insseco, commencing December 31, 2014.

** Net income used for earning per share was adjusted to reflect the effect of redeemable non-controlling interest.

Summary of Non-GAAP Financial Information

U.S. dollars in thousands (except per share amounts)

Three months ended
September 30,
Nine months ended
September 30,
2016
(unaudited)
2015
(unaudited)
2016
(unaudited)
2015
(unaudited)
Revenues 56,480 100% 46,139 100% 159,077 100% 130,589 100%
Gross Profit 23,617 41.8% 20,711 44.9% 67,917 42.7% 56,957 43.6%
Operating profit 7,348 13.0% 6,962 15.1% 22,122 13.9% 19,191 14.7%
Net income to shareholders 6,004 10.6% 5,816 12.6% 18,241 11.5% 15,773 12.1%
Adjusted EBITDA 8,115 14.4% 7,493 16.2% 24,152 15.2% 20,571 15.8%
Basic earnings per share 0.12 0.12 0.37 0.33
Diluted earnings per share 0.12 0.12 0.37 0.32

Non-GAAP revenues by geographic breakdown

U.S. dollars in thousands

Q3 2016 Q2 2016 Q1 2016 Q4 2015 Q3 2015
North America 19,706 17,601 16,041 16,767 16,571
Europe 28,675 26,124 28,421 26,439 24,084
APAC 8,099 9,305 5,105 5,468 5,484
Total 56,480 53,030 49,567 48,674 46,139

Adjusted EBITDA Calculation

U.S. dollars in thousands

Three months ended
September 30,
Nine months ended
September 30,
2016 2015 2016 2015
GAAP operating profit 6,591 5,726 19,249 17,554
Non GAAP adjustments:
Amortization of capitalized software 1,172 1,202 3,837 3,552
Amortization of other intangible assets 658 585 1,664 1,714
Capitalization of software development (1,674) (1,526) (4,454) (4,391)
Stock-based compensation 493 346 1,433 914
Compensation related to acquisition and
acquisition related costs
Adjustments of pre-acquisition revenues
108 148 393 219
and expenses accounted under pooling
of interest method
- 481 - (371)
Non GAAP operating profit 7,348 6,962 22,122 19,191
Depreciation 767 531 2,030 1,380
Adjusted EBITDA 8,115 7,493 24,152 20,571

SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES RECONCILIATION OF GAAP TO NON-GAAP RESULTS

U.S. dollars in thousands (except per share amounts)

Three months ended
September 30,
Nine months ended
September 30,
2016 2015 2016 2015
GAAP revenue 56,480 47,035 159,077 136,962
Adjustments of pre-acquisition revenue accounted under pooling
of interest method - (896) - (6,373)
Non-GAAP revenue 56,480 46,139 159,077 130,589
GAAP gross profit 22,114 19,091 63,323 54,403
Revenue adjustment - (896) - (6,373)
Amortization of capitalized software 1,172 1,202 3,837 3,552
Amortization of other intangible assets 331 234 757 643
Adjustments of pre-acquisition cost of revenue accounted under
pooling of interest method
- 1,080 - 4,732
Non-GAAP gross profit 23,617 20,711 67,917 56,957
GAAP operating income 6,591 5,726 19,249 17,554
Gross profit adjustments 1,503 1,620 4,594 2,554
Capitalization of software development (1,674) (1,526) (4,454) (4,391)
Amortization of other intangible assets 327 351 907 1,071
Stock-based compensation 493 346 1,433 914
Compensation related to acquisition and acquisition related costs 108 148 393 219
Adjustments of pre-acquisition operating expenses accounted - 297 - 1,270
under pooling of interest method
Non-GAAP operating income 7,348 6,962 22,122 19,191
GAAP net income attributable to Sapiens' shareholders 5,305 4,689 15,525 14,144
Operating income adjustments 757 1,236 2,873 1,637
Adjustment to redeemable non-controlling interest 38 (23) 141 73
Adjustments of pre-acquisition financial and tax expenses - (116) - 50
accounted under pooling of interest method
Other (96) 30 (298) (131)
Non-GAAP net income attributable to Sapiens' shareholders 6,004 5,816 18,241 15,773
Non-GAAP basic earnings per share 0.12 0.12 0.37 0.33
Non-GAAP diluted earnings per share 0.12 0.12 0.37 0.32
Weighted average number of shares outstanding used to compute
basic earnings per share (in thousands)
49,002 48,128 48,922 47,869
Weighted average number of shares outstanding used to compute
diluted earnings per share (in thousands)
49,849 49,484 49,722 49,254

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS

U.S. Dollars in thousands

September 30,
2016
December 31,
2015
(unaudited) (unaudited)
ASSETS
CURRENT ASSETS:
Cash and cash equivalents 56,228 54,351
Trade receivables, net 30,300 29,761
Other receivables and prepaid expenses 8,614 5,455
Marketable securities 25,128 8,776
Total current assets 120,270 98,343
LONG-TERM ASSETS:
Marketable securities 15,333 30,875
Property and equipment, net 10,150 5,675
Severance pay fund 4,281 5,551
Other intangible assets, net 29,550 27,540
Other long-term assets 4,872 4,252
Goodwill 75,363 70,035
Total long-term assets 139,549 143,928
TOTAL ASSETS 259,819 242,271
LIABILITIES AND EQUITY
CURRENT LIABILITIES:
Trade payables 7,262 4,721
Accrued expenses and other liabilities 31,828 32,012
Deferred revenue 12,792 10,268
Total current liabilities 51,882 47,001
LONG-TERM LIABILITIES:
Other long-term liabilities 8,203 6,414
Accrued severance pay 5,222 6,662
Total long-term liabilities 13,425 13,076
REDEEMABLE NON-CONTROLLING INTEREST 385 385
EQUITY 194,127 181,809
TOTAL LIABILITIES AND EQUITY 259,819 242,271

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES CONSOLIDATED STATEMENT OF CASH FLOW

U.S. dollars in thousands

For the Nine months ended
September 30,
2016 2015*
(unaudited) (unaudited)
Cash flows from operating activities:
Net income
15,491 14,294
Reconciliation of net income to net cash provided by operating activities:
Depreciation and amortization 7,531 7,302
Amortization of premium and accrued interest on marketable securities (380) (313)
Stock-based compensation related to options issued to employees 1,433 913
Net changes in operating assets and liabilities, net of amount acquired:
Trade receivables 11 (625)
Deferred tax assets 366 541
Other operating assets (3,383) 449
Trade payables 1,231 1,618
Other operating liabilities (254) 3,974
Deferred revenues 2,203 767
Severance pay (210) (288)
Net cash provided by operating activities 24,039 28,632
Cash flows from investing activities:
Purchase of property and equipment (3,732) (2,229)
Purchase of marketable securities, net of interest received (5,605) (7,220)
Proceeds from sales of marketable securities 5,394 1,015
Payments for business acquisition, net of cash acquired (4,861) (2,934)
Capitalized software development costs
Restricted cash
(4,454)
4
(4,391)
(1,395)
Net cash used in investing activities (13,254) (17,154)
Cash flows from financing activities:
Proceeds from employee stock options exercised 809 1,557
Payment to shareholders in respect of acquisition (1,440) (6,349)
Distribution of dividend (9,786) (7,186)
Repayment of loan (642) -
Net cash used in financing activities (11,059) (11,978)
Effect of exchange rate changes on cash and cash equivalents 2,151 (1,736)
Increase in cash and cash equivalents 1,877 (2,236)
Cash and cash equivalents at the beginning of period 54,351 47,400
Cash and cash equivalents at the end of period 56,228 45,164
*Including consolidation of Insseco, commencing December 31, 2014.